TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 3 | -3 | -4 | -8 | 13 | -37 | 5 | -6 |
| S | %wins | 67 | 67 | 100 | 33 | 100 | 33 | 67 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
10/6/15 06:11 | 10/1/15 | BLCM | Bellicum Pharmaceuticals, Inc | Health | Drug | Pharmaceutical Preparations | Farrell Thomas J. | TX | DO | P,CEO | S | -36 | 14.58 | 7 | -3 | -4 | 64 | D | -33 | -19 | -4 | -20 | -10 | 9 | -9 | -10 | -5 | 22 | -30 | 27 | |||
9/3/15 16:55 | 9/1/15 | BLCM | Bellicum Pharmaceuticals, Inc | Health | Drug | Pharmaceutical Preparations | Farrell Thomas J. | TX | DO | P,CEO | S | -42 | 16.78 | 6 | -3 | -4 | 66 | D | -31 | -34 | -10 | -5 | 2 | -3 | 1 | 10 | -3 | 43 | -31 | 9 | |||
8/5/15 17:07 | 8/3/15 | BLCM | Bellicum Pharmaceuticals, Inc | Health | Drug | Pharmaceutical Preparations | Farrell Thomas J. | TX | DO | P,CEO | S | -51 | 20.24 | 5 | -3 | -4 | 69 | D | -13 | -11 | -11 | 4 | 8 | 1 | -2 | -11 | -17 | -27 | -50 | -20 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |